• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利队列研究未发现多发性硬化症与六核苷酸重复序列大小相关。

No Association of Multiple Sclerosis with Hexanucleotide Repeat Size in an Austrian Cohort.

机构信息

Department of Neurology, Medical University of Vienna, 1090 Vienna, Austria.

Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, 1090 Vienna, Austria.

出版信息

Int J Mol Sci. 2023 Jul 9;24(14):11254. doi: 10.3390/ijms241411254.

DOI:10.3390/ijms241411254
PMID:37511014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378763/
Abstract

Multiple Sclerosis (MS) is a common immune-mediated disorder of the central nervous system that affects young adults and is characterized by demyelination and neurodegeneration. Recent studies have associated intermediate repeat expansions with MS. The objective of this study was to investigate whether repeat length is associated with MS or with a specific disease course in a monocentric Austrian MS cohort. Genotyping of 382 MS patients and 643 non-neurological controls for repeat expansions was performed. The study did not find a difference in the distribution of repeat numbers between controls and MS cases (median repeat units = 2; = 0.39). Additionally, sub-analysis did not establish a link between intermediate repeats and MS ( = 0.23) and none of the patients with progressive disease course carried an intermediate allele (20-30 repeat units). Exploratory analysis for different cut-offs (of ≥7, ≥17, and ≥24) did not reveal any significant differences in allele frequencies between MS and controls. However, the study did identify a progressive MS patient with a pathogenic expansion and probable co-existing behavioral variant frontotemporal dementia (bvFTD) in a retrospective chart review. In conclusion, this study did not find evidence supporting an association between repeat length and MS or a specific disease course in the Austrian MS cohort. However, the identification of a progressive MS patient with a pathogenic expansion and probable co-existing with FTD highlights the complexity and challenges involved in recognizing distinct neurodegenerative diseases that may co-occur in MS patients.

摘要

多发性硬化症(MS)是一种常见的中枢神经系统免疫介导疾病,影响年轻人,其特征是脱髓鞘和神经退行性变。最近的研究将中间重复扩展与 MS 相关联。本研究的目的是调查在一个奥地利单中心 MS 队列中,重复长度是否与 MS 或特定疾病过程相关。对 382 名 MS 患者和 643 名非神经科对照进行 重复扩展的基因分型。研究未发现对照组和 MS 病例之间重复数分布的差异(中位数重复单位= 2;= 0.39)。此外,亚分析未建立中间重复与 MS 之间的联系(= 0.23),并且没有进展性疾病过程的患者携带中间等位基因(20-30 重复单位)。对不同截止值(≥7、≥17 和≥24)的探索性分析未显示 MS 和对照组之间等位基因频率的任何显著差异。然而,该研究确实在回顾性图表审查中发现了一名进行性 MS 患者,其具有致病性 扩展和可能并存的行为变异额颞叶痴呆(bvFTD)。总之,本研究未发现支持奥地利 MS 队列中重复长度与 MS 或特定疾病过程之间存在关联的证据。然而,识别出一名进行性 MS 患者具有致病性 扩展和可能与额颞叶痴呆并存,突出了识别可能在 MS 患者中同时发生的不同神经退行性疾病的复杂性和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/10378763/92509aa37e1d/ijms-24-11254-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/10378763/92509aa37e1d/ijms-24-11254-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c31/10378763/92509aa37e1d/ijms-24-11254-g001.jpg

相似文献

1
No Association of Multiple Sclerosis with Hexanucleotide Repeat Size in an Austrian Cohort.奥地利队列研究未发现多发性硬化症与六核苷酸重复序列大小相关。
Int J Mol Sci. 2023 Jul 9;24(14):11254. doi: 10.3390/ijms241411254.
2
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.C9orf72 重复长度可能会影响痴呆症患者的临床亚型。
Neurobiol Dis. 2022 Dec;175:105927. doi: 10.1016/j.nbd.2022.105927. Epub 2022 Nov 13.
3
C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.C9orf72 中间等位基因在肌萎缩侧索硬化症、系统性红斑狼疮和类风湿关节炎患者中的研究。
Neuromolecular Med. 2019 Jun;21(2):150-159. doi: 10.1007/s12017-019-08528-8. Epub 2019 Mar 11.
4
OPTN p.Met468Arg and ATXN2 intermediate length polyQ extension in families with C9orf72 mediated amyotrophic lateral sclerosis and frontotemporal dementia.在C9orf72介导的肌萎缩侧索硬化症和额颞叶痴呆症家族中,OPTN基因的p.Met468Arg突变以及ATXN2基因中等长度的多聚谷氨酰胺扩展。
Am J Med Genet B Neuropsychiatr Genet. 2018 Jan;177(1):75-85. doi: 10.1002/ajmg.b.32606. Epub 2017 Oct 28.
5
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions.C9ORF72 六核苷酸重复扩展的临床和病理学表型。
Brain. 2012 Mar;135(Pt 3):723-35. doi: 10.1093/brain/awr353. Epub 2012 Feb 1.
6
No C9orf72 repeat expansion in patients with primary progressive multiple sclerosis.未在原发性进行性多发性硬化症患者中发现 C9orf72 重复扩展。
Mult Scler Relat Disord. 2018 Oct;25:192-195. doi: 10.1016/j.msard.2018.07.047. Epub 2018 Aug 1.
7
C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels.C9orf72 肌萎缩侧索硬化症-额颞叶变性:多个层面自噬溶酶体途径失调的最新证据。
Autophagy. 2021 Nov;17(11):3306-3322. doi: 10.1080/15548627.2021.1872189. Epub 2021 Feb 26.
8
C9orf72 hexanucleotide repeat length in older population: normal variation and effects on cognition.C9orf72 六核苷酸重复长度在老年人群中的变化:正常变异及其对认知的影响。
Neurobiol Aging. 2019 Dec;84:242.e7-242.e12. doi: 10.1016/j.neurobiolaging.2019.02.026. Epub 2019 Mar 11.
9
Identification of C9orf72 repeat expansions in patients with amyotrophic lateral sclerosis and frontotemporal dementia in mainland China.中国大陆肌萎缩侧索硬化症和额颞叶痴呆患者中C9orf72重复序列扩增的鉴定。
Neurobiol Aging. 2014 Apr;35(4):936.e19-22. doi: 10.1016/j.neurobiolaging.2013.10.001. Epub 2013 Oct 5.
10
Unravelling the clinical spectrum and the role of repeat length in repeat expansions.解析重复扩展的临床谱及其重复长度的作用。
J Neurol Neurosurg Psychiatry. 2021 May;92(5):502-509. doi: 10.1136/jnnp-2020-325377. Epub 2021 Jan 15.

本文引用的文献

1
C9orf72 repeat length might influence clinical sub-phenotypes in dementia patients.C9orf72 重复长度可能会影响痴呆症患者的临床亚型。
Neurobiol Dis. 2022 Dec;175:105927. doi: 10.1016/j.nbd.2022.105927. Epub 2022 Nov 13.
2
Diagnosis of coexistent neurodegenerative dementias in multiple sclerosis.多发性硬化中共存神经退行性痴呆的诊断
Brain Commun. 2022 Jun 22;4(4):fcac167. doi: 10.1093/braincomms/fcac167. eCollection 2022.
3
The immunology of multiple sclerosis.多发性硬化症的免疫学
Nat Rev Immunol. 2022 Dec;22(12):734-750. doi: 10.1038/s41577-022-00718-z. Epub 2022 May 4.
4
Primary progressive aphasias associated with C9orf72 expansions: Another side of the story.与C9orf72基因扩增相关的原发性进行性失语症:故事的另一面。
Cortex. 2021 Dec;145:145-159. doi: 10.1016/j.cortex.2021.09.005. Epub 2021 Oct 1.
5
Mechanistic underpinning of an inside-out concept for autoimmunity in multiple sclerosis.多发性硬化症自身免疫的内-外概念的机制基础。
Ann Clin Transl Neurol. 2021 Aug;8(8):1709-1719. doi: 10.1002/acn3.51401. Epub 2021 Jun 22.
6
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?分析神经科患者回顾性队列中的 C9orf72 中间等位基因:阿尔茨海默病的危险因素?
J Alzheimers Dis. 2021;81(4):1445-1451. doi: 10.3233/JAD-210249.
7
Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances.复发型多发性硬化的细胞免疫学:相互作用、检查和平衡。
Lancet Neurol. 2021 Jun;20(6):470-483. doi: 10.1016/S1474-4422(21)00063-6. Epub 2021 Apr 27.
8
Unravelling the clinical spectrum and the role of repeat length in repeat expansions.解析重复扩展的临床谱及其重复长度的作用。
J Neurol Neurosurg Psychiatry. 2021 May;92(5):502-509. doi: 10.1136/jnnp-2020-325377. Epub 2021 Jan 15.
9
C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy.C9orf72 中间重复序列与皮质基底节变性、C9orf72 表达增加和自噬破坏有关。
Acta Neuropathol. 2019 Nov;138(5):795-811. doi: 10.1007/s00401-019-02045-5. Epub 2019 Jul 20.
10
C9orf72 intermediate expansions of 24-30 repeats are associated with ALS.C9orf72 中间重复数为 24-30 的扩展与 ALS 相关。
Acta Neuropathol Commun. 2019 Jul 17;7(1):115. doi: 10.1186/s40478-019-0724-4.